Authors: BAZZINO O AYLWARD P HAINS A SLANY J STEINBACH K VANDEWERF F VRINTS C COELHO O RAMIRES J BOGATY P BOUDREAULT J DIODATI J GOSSARD D KOUZ S LARAMEE P LEMAY M MAILLETTE S THEROUX P BOTERO R ARCE M HEIKKILA J DANCHIN D WEBER S KROMER EP NEUMANN FJ NIENABER C KATRITSIS D PAPAZAGLOU N BENHORIN J DAVID D TZIVONI D GUAZZI M MOGUEL R VERDEJO J BONNIER J DEZWAAN C HAMER AW WHITE HD AARONES M ARVESEN K FOSSUM E HENESTAM B ROLLAG A RIBEIRO V COMMERFORD P LANDLESS P MARX J WEICH H ANCILLO P CATURLA J CIVEIRA E FERRERO J FIGUERAS J GINESTAL R RUANO M ERHARDT L SYLVEN C LUSCHER T MOCCETTI T ADAMS P ADGEY AAJ BULLER N CANEPA R FURNISS S GREENBAUM R HALL J JENNINGS K KOONER J LEVY R LIPKIN D NOBLE M ROTHMAN M ABRAHAMSON D AGUIRRE F AMBROSE J ANDERSON HV ANDERSON J ARORA R BABB J BHASIN S BITTAR N BOTTI R BOWLES M BROWN A COHEN M COLFER H DALEY W DAWLEY D DETRANO R EISENBERG P FARHAT N FAXON D FREY M FRIEDMAN S GOLDSCHLAGER N GRADMAN A GUTIERREZ F HATTEMER C HERRMANN H HOCHMAN J ISRAEL N KIERNAN J KOREN M KRAMER J LING F MEHTA J MODY F MOHIUDDIN S NAFZIGER A NAIR R NIEDERMAN A PALABRICA T RODRIGUEZ S ROSENSON R RUTHERFORD J SCHMEDTJE J SHAH PK SHARMA S SMITH S SMITHERMAN T STILLABOWER M TIERSTEIN P VAUGHAN D WATERS D WEINSTOCK P WILLIAMS M YAKUBOV S ZOBLE R KLEIMAN NS LIPSCHUTZ KH SAX FL CAIRNS J ESPELAND M FITZGERALD G VERSTRAETE M WEAVER WD WILLIAMS DO DREIFUS LS NASMITH J RUNGE M GROSSMAN W SNAPINN SM BREMER M FRAME V HUTNYAN J LAPPE JT SERGIO M THORNTON A

Citation: O. Bazzino et al., A COMPARISON OF ASPIRIN PLUS TIROFIBAN WITH ASPIRIN PLUS HEPARIN FOR UNSTABLE ANGINA, The New England journal of medicine, 338(21), 1998, pp. 1498-1505

Authors: CLEMONS MJ MARSHALL E DURIG J WATANABE K HOWELL A MILES D EARL H KIERNAN J GRIFFITHS A TOWLSON K DETAKATS P TESTA NG DOUGAL M HUNTER MG WOOD LM CZAPLEWSKI LG MILLAR A DEXTER TM LORD BI

Citation: Mj. Clemons et al., RANDOMIZED PHASE-II STUDY OF BB-10010 (MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA) IN PATIENTS WITH ADVANCED BREAST-CANCER RECEIVING 5-FLUOROURACIL, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY, Blood, 92(5), 1998, pp. 1532-1540

Authors: MAITI IB GHOSH SK GOWDA S KIERNAN J SHEPHERD RJ

Citation: Ib. Maiti et al., PROMOTER LEADER DELETION ANALYSIS AND PLANT EXPRESSION VECTORS WITH THE FIGWORT MOSAIC-VIRUS (FMV) FULL-LENGTH TRANSCRIPT (FLT) PROMOTER CONTAINING SINGLE OR DOUBLE ENHANCER DOMAINS/, Transgenic research, 6(2), 1997, pp. 143-156

Authors: KIERNAN J

Citation: J. Kiernan, BENCHMARKING FROM A BEGINNERS PERSPECTIVE, Total quality management, 8(2-3), 1997, pp. 202-204

Authors: ODOHERTY B PILFORS G QUINN PT HOWARD A BRADBURY F SCULLY M CLARKE O KIERNAN J RYAN MF OKELLY P WILLIAMS PA KHONG TK HAMILL JJ BURMAN A KHATRI CP AGRAWAL P SOARES P HUGHES I

Citation: B. Odoherty et al., AZITHROMYCIN VERSUS PENICILLIN-V IN THE TREATMENT OF PEDIATRIC-PATIENTS WITH ACUTE STREPTOCOCCAL PHARYNGITIS TONSILLITIS, European journal of clinical microbiology & infectious diseases, 15(9), 1996, pp. 718-724

Authors: KIERNAN J CAREY MJ

Citation: J. Kiernan et Mj. Carey, EXTENDING SQL-92 FOR OODB ACCESS - DESIGN AND IMPLEMENTATION EXPERIENCE, ACM SIGPLAN NOTICES, 30(10), 1995, pp. 467-480